GeoVax Raises $3.65M via Warrant Inducement to Fund Vaccine Pipeline
GeoVax Labs secures $3.65M through warrant exercise to fund GEO-MVA vaccine and Gedeptin cancer therapy. Learn about the impact on biotech development.
This news matters because it provides GeoVax with essential capital to advance its vaccine and cancer therapy programs, addressing critical public health needs such as mpox and smallpox preparedness, and potentially improving cancer treatment options.